Author:
Singh Ospina Naykky M.,Rodriguez-Gutierrez Rene,Maraka Spyridoula,Espinosa de Ycaza Ana E.,Jasim Sina,Castaneda-Guarderas Ana,Gionfriddo Michael R.,Al Nofal Alaa,Brito Juan P.,Erwin Patricia,Richards Melanie,Wermers Robert,Montori Victor M.
Funder
CTSA from the National Center for Advancing Translational Science (NCATS)a component of the National Institutes of Health (NIH)
CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).
Publisher
Springer Science and Business Media LLC
Reference115 articles.
1. Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569
2. Yeh MW, Ituarte PH, Zhou HC et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98(3):1122–1129
3. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA (2014) Secular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010). Bone 73C:1–7
4. Wermers RA, Khosla S, Atkinson EJ et al (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Mineral Res Off J Am Soc Bone Mineral Res 21(1):171–177
5. Ruda JM, Hollenbeak CS, Stack BC Jr (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132(3):359–372
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献